Aptevo Therapeutics Inc. Retained Earnings
Aptevo Therapeutics Inc. (APVO) had Retained Earnings of -$288.26 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$288.26M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$281.91M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$275.12M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$269.22M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$288.26M 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$281.91M 10-Q · filed 2026-05-13 |
| 2025-12-31 | -$275.12M 10-Q · filed 2026-08-14 |
| 2025-09-30 | -$269.22M 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$260.19M 10-Q · filed 2025-08-11 |
| 2025-03-31 | -$253.99M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$247.58M 10-K · filed 2026-03-26 |
| 2024-09-30 | -$241.26M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$236.16M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$230.28M 10-Q · filed 2024-05-08 |
| 2023-12-31 | -$223.45M 10-K · filed 2025-02-14 |
| 2023-09-30 | -$217.54M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$211.21M 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$203.26M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$206.04M 10-K · filed 2024-03-05 |
| 2022-09-30 | -$201.39M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$193.75M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$221.76M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$214.06M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$207.79M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$200.79M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$192.86M 10-Q · filed 2021-05-11 |
| 2020-12-31 | -$185.61M 10-K · filed 2022-03-24 |
| 2020-09-30 | -$178.55M 10-Q · filed 2020-11-10 |
| 2020-06-30 | -$171.76M 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$164.96M 10-Q · filed 2020-05-13 |
| 2019-12-31 | -$167.86M 10-K · filed 2021-03-31 |
| 2019-09-30 | -$159.68M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$152.76M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$139.43M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$127.41M 10-K · filed 2020-03-25 |
| 2018-09-30 | -$113.28M 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$100.72M 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$87.57M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$73.72M 10-K · filed 2019-03-18 |
| 2017-09-30 | -$63.96M 10-Q · filed 2017-11-13 |
| 2017-06-30 | -$101.83M 10-Q · filed 2017-08-10 |
| 2017-03-31 | -$90.64M 10-Q · filed 2017-05-12 |
| 2016-12-31 | -$80.69M 10-K · filed 2018-03-13 |
| 2016-09-30 | -$65.75M 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$257.72M 10-Q/A · filed 2016-09-22 |
| 2015-12-31 | -$231.99M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |